JapanStake
Pharmaceutical · Fiscal year end Mar 31

Nano Holdings, Inc.

4571

NANOホールディングス株式会社

FIGI BBG000V9N9K84571.T4571 JPCorp. no. 5040001067344

Latest half-year results

First half · fiscal year to 2026-03 · filed 2025-11-14

For the first half of the fiscal year to 2026-03: Revenue ¥0 billion (+433.8% YoY), Ordinary income ¥-0.4 billion, Net income ¥-0.4 billion.

This periodYear on year
Revenue¥41m+433.8%
Ordinary profit−¥385m—
Net profit to owners−¥440m—

From the securities report on EDINET, which states no forecast. History via /v1/companies/4571/earnings-releases.

Financials

Japan GAAP · consolidated · fiscal year to 2026-03-31
Revenue
¥174m
Net income
−¥944m
ROE
—
Equity ratio
59.9%
Dividend / share
—
Employees
23
Revenue · ¥m
FY2023: ¥202m 202 FY2023FY2024: ¥136m 136 FY2024FY2025: ¥109m 109 FY2025FY2026: ¥174m 174 FY2026
Net income · ¥bn
FY2023: −¥1.3bn -1.31 FY2023FY2024: −¥0.8bn -0.78 FY2024FY2025: −¥0.8bn -0.84 FY2025FY2026: −¥0.9bn -0.94 FY2026
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2026-03-31¥174m−¥944m¥5,906m¥3,566m—¥-12.9−¥817m
2025-03-31¥109m−¥835m¥3,997m¥2,740m—¥-11.85−¥402m
2024-03-31¥136m−¥780m¥5,071m¥3,421m—¥-11.1−¥585m
2023-03-31¥202m−¥1,311m¥5,784m¥4,253m—¥-18.7−¥1,087m

Indicators

Computed by us from filings · fiscal year to 2026-03-31
MetricValuePercentile among listed companies
ROE, %——
Ordinary margin-4.96820.5
Equity ratio, %59.958.1
Revenue growth0.60898.2
Net income growth-0.129926.4
Operating cash flow / assets-0.13833.6
Policy-uncertainty measure0.00 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change −2.99pt in 90 days; 0.8% held by other listed companies.

Results wording balance: +1.00. Proprietary text method; it describes the wording only and does not interpret context.

Interest example: if all ¥1.6bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥8m. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.

Via /v1/companies/4571/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Internal control, 2026-06-26: see filing 上記の評価の結果、当連結会計年度末日時点において、当社グループの財務報告に係る内部統制は有効であると判断いたしました。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Latest voting result: 2026-06-30 · 取締役8名選任の件 · passed. /v1/companies/4571/voting

Ownership changes

All companies →

Trades by 5% holders

From the 60-day trade tables in 5% reports
¥108¥143¥178 2026-03-052026-08-20 2026-08-20 · sold 5,000 @ ¥108 · 株式会社SBI証券2026-04-08 · sold 57,900 @ ¥157 · 株式会社SBI証券2026-03-05 · sold 10,800 @ ¥178 · 株式会社SBI証券
Bought SoldHover a dot for the trade
HolderPeriodNet sharesNet % of sharesAvg. filed priceRange
株式会社SBI証券2025-09-01 – 2026-10-01+25,300,964+23.67pt¥159.66¥108–226
アクセリード株式会社2023-06-12 – 2025-09-220−0.09pt——
株式会社IPガイア2023-06-12 – 2025-09-220−0.09pt——
株式会社ウィズ・パートナーズ2021-12-22 – 2025-09-22-13,473,966−18.70pt——

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4571/trades.

5% filings

Large shareholding reports on 4571
FiledFilerStakeChangeStated purpose
2026-10-08SBI SECURITIES Co., Ltd.23.10%−1.81pt—
2026-08-27SBI SECURITIES Co., Ltd.24.91%−1.18pt—
2026-06-04SBI SECURITIES Co., Ltd.26.09%−0.95pt—
2026-04-03SBI SECURITIES Co., Ltd.27.04%−1.07pt—
2026-03-12SBI SECURITIES Co., Ltd.28.11%−1.24pt—
2026-03-04SBI SECURITIES Co., Ltd.29.35%−1.13pt—
2026-02-24SBI SECURITIES Co., Ltd.30.48%−1.89pt—
2026-02-18SBI SECURITIES Co., Ltd.32.37%−1.04pt—
2026-01-13SBI SECURITIES Co., Ltd.33.41%−1.02pt—
2025-12-12SBI SECURITIES Co., Ltd.34.43%−1.35pt—

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
1 issues
Book value
¥243m
Sold in the year
— — issues
Bought in the year
— — issues
Mutual, both reports
0
Held by listed cos.
1
HoldsBook valueShares vs. prior yearMutual
Kidswell Bio Corporation 4584¥243m0.0%no

Held by: Shin-Etsu Chemical Co., Ltd. 4063

Purposes, all holdings and mutual flags via /v1/companies/4571/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2026-03-31
ShareholderSharesRatio
セントラル短資株式会社1,635,3001.99%
株式会社SBI証券1,606,5711.96%
松井証券株式会社1,116,5001.36%
上田八木短資株式会社1,100,0001.34%
individual holder1,005,0001.22%
楽天証券株式会社942,4001.15%
ノーリツ鋼機株式会社750,0000.91%
マネックス証券株式会社673,7460.82%
京滋建設株式会社640,9000.78%
信越化学工業株式会社625,0000.76%

Get this as JSON

GET /v1/companies/4571
GET /v1/companies/4571/financials
GET /v1/companies/4571/details
GET /v1/companies/4571/segments
GET /v1/companies/4571/voting
GET /v1/companies/4571/tender-offers
GET /v1/companies/4571/indicators
GET /v1/companies/4571/earnings-releases
GET /v1/events?ticker=4571
GET /v1/companies/4571/trades         
GET /v1/companies/4571/cross-holdings 
GET /v1/companies/4571/brief          

Plans from $9 a month · Documentation